Pulmonary Testing Summary of Clinical Indications

Ventilation-Perfusion Lung Scan:


Pulmonary Function Tests
1) Spirometry and flow volume loop
2) Carbon Monoxide Diffusing Capacity
3) Functional Residual Capacity
4) Oximetry

 
Home > For Doctors > Pulmonary Testing Summary of Clinical Indications

Ventilation Perfusion Scan
Click for full image (63k).

Ventilation-Perfusion Lung Scan:

  • to determine the likelihood of pulmonary emboli
  • less common indications include:
    • evaluation of lung transplantation
    • preoperative evaluation
    • right-to-left shunt evaluation

Pulmonary Function Testing
Pulmonary function testing is performed most commonly to:

  • Assist in a differential diagnosis
  • Estimate prognosis
  • Follow the course of a disease or its response to therapy.
  • Estimate the risk or procedures or therapy.
  • Detect untoward reactions to drugs.
  • Assess functional impairment and/or disability.






Ventilation-Perfusion Lung Scan


Pulmonary Function Tests
1) Spirometry and flow volume loop
2) Carbon Monoxide Diffusing Capacity
3) Functional Residual Capacity
4) Oximetry

Back to the top



















Back to the top
1) Spirometry and flow volume loop
  • Evaluate respiratory symptoms, especially dyspnea, wheeze, stridor and persistent cough.
  • Evaluate abnormal laboratory tests, such as hypoxemia, hypercapnia, polycythemia, etc.
  • Diagnose an obstructive or restrictive ventilatory impairment, or any extrathoracic upper airway obstruction.
  • Help assess peri-operative risk or exercise capacity.
  • Monitor the course of chronic obstructive lung diseases, such as asthma and COPD.
  • Monitor the course or chronic restrictive diseases, such as fibrosing alveolitis or a neuromuscular disorder.
  • Evaluate the response to specific therapy for a respiratory condition.
  • Help validate subjective complaints in occupational or environmental settings.

2) Carbon Monoxide Diffusing Capacity

  • Establish the presence of parenchymal lung disease in patients with an obstructive ventilatory impairment ( e.g. differentiating asthma from underlying emphysema).
  • Establish the presence of parenchymal lung disease in patients with a restrictive ventilatory impairment (e.g. differentiate intrinsic lung disease from an extrapulmonary process)
  • Establish the presence parenchymal lung disease in patients with otherwise normal pulmonary function studies (e.g. asbestosis, fibrosing alveolitis, drug-induced or radiation pneumonitis, pheumoncystis pneumonia.)
  • Help assess disease severity in patients with parenchymal or pulmonary vascular disease and to estimate functional impairment and/or disability.
  • Help monitor patients with pulmonary haemorrhage syndromes.

3) Functional Residual Capacity

  • Confirm a diagnosis suspected by spirometry.
  • In a restrictive disease, diagnose a respiratory disorder not clearly evident from spirometry or to help assess disease severity.
  • Help monitor the progression of parenchymal lung disease or assess its response to therapy.

4) Oximetry

  • Estimate oxygen saturation in a patient at rest with or without supplemental oxygen therapy.
  • Document changes in oxygen saturation with exercise, (usually in patients with SaO2 > 90% at rest).
  • Document improvement in oxygen saturation following change in therapy or in level of oxygen supplementation.
   

HOME | What's New | How to Find Us | About Us | F.A.Q. | Contact Us | FOR PATIENTS

© 2003, Norfolk Nuclear Medicine Service. Disclaimer.